As of close of business last night, Thermo Fisher Scientific Inc.’s stock clocked out at $555.96, up 2.66% from its previous closing price of $541.56. In other words, the price has increased by $+14.75 from its previous closing price. On the day, 1409629 shares were traded. TMO stock price reached its highest trading level at $561.48 during the session, while it also had its lowest trading level at $545.00.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Ratios:
To gain a deeper understanding of TMO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.66.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on December 14, 2022, initiated with a Buy rating and assigned the stock a target price of $620.
On December 07, 2022, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $661.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 14 when CASPER MARC N sold 1,600 shares for $571.96 per share. The transaction valued at 915,132 led to the insider holds 128,705 shares of the business.
CASPER MARC N sold 10,000 shares of TMO for $5,744,836 on Feb 13. The Chairman & CEO now owns 128,705 shares after completing the transaction at $574.48 per share. On Feb 10, another insider, CASPER MARC N, who serves as the Chairman & CEO of the company, sold 20,000 shares for $569.18 each. As a result, the insider received 11,383,631 and left with 128,705 shares of the company.
Valuation Measures:
As of this moment, Thermo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 31.52, and their Forward P/E ratio for the next fiscal year is 20.78. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.85 while its Price-to-Book (P/B) ratio in mrq is 4.96.
Stock Price History:
Over the past 52 weeks, TMO has reached a high of $618.35, while it has fallen to a 52-week low of $475.77. The 50-Day Moving Average of the stock is 565.26, while the 200-Day Moving Average is calculated to be 549.12.
Shares Statistics:
It appears that TMO traded 1.43M shares on average per day over the past three months and 1.18M shares per day over the past ten days. A total of 392.00M shares are outstanding, with a floating share count of 384.43M. Insiders hold about 0.10% of the company’s shares, while institutions hold 91.00% stake in the company. Shares short for TMO as of Jan 12, 2023 were 3.05M with a Short Ratio of 2.50M, compared to 3.04M on Dec 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.78% and a Short% of Float of 0.78%.
Dividends & Splits
With its trailing 12-month dividend rate of 0.92, TMO has a forward annual dividend rate of 1.40. Against a Trailing Annual Dividend Yield of 0.17%, it implies a Forward Annual Dividend Yield of 0.21%. The stock’s 5-year Average Dividend Yield is 0.23. The current Payout Ratio is 6.50% for TMO, which recently paid a dividend on Apr 13, 2023 with an ex-dividend date of Dec 13, 2022. Stock splits for the company last occurred on Jun 05, 1996 when the company split stock in a 3:2 ratio.
Earnings Estimates
As of right now, 21 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $5.05 for the current quarter, with a high estimate of $5.85 and a low estimate of $4.78, while EPS last year was $7.25. The consensus estimate for the next quarter is $5.67, with high estimates of $6.03 and low estimates of $5.43.
Analysts are recommending an EPS of between $24 and $23.21 for the fiscal current year, implying an average EPS of $23.73. EPS for the following year is $26.74, with 23 analysts recommending between $28.02 and $24.86.
Revenue Estimates
In the current quarter, 18 analysts expect revenue to total $10.68B. It ranges from a high estimate of $11.1B to a low estimate of $10.29B. As of the current estimate, Thermo Fisher Scientific Inc.’s year-ago sales were $11.82B, an estimated decrease of -9.70% from the year-ago figure. For the next quarter, 18 analysts are estimating revenue of $11.11B, an increase of 1.30% over than the figure of -$9.70% in the same quarter last year. There is a high estimate of $11.36B for the next quarter, whereas the lowest estimate is $10.76B.
A total of 23 analysts have provided revenue estimates for TMO’s current fiscal year. The highest revenue estimate was $46.14B, while the lowest revenue estimate was $44.46B, resulting in an average revenue estimate of $45.34B. In the same quarter a year ago, actual revenue was $44.91B, up 0.90% from the average estimate. Based on 22 analysts’ estimates, the company’s revenue will be $49.08B in the next fiscal year. The high estimate is $51.32B and the low estimate is $47.97B. The average revenue growth estimate for next year is up 8.20% from the average revenue estimate for this year.
